<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-1249</journal-id>
<journal-title><![CDATA[Archivos de Pediatría del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Pediatr. Urug.]]></abbrev-journal-title>
<issn>1688-1249</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Pediatría]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-12492020000400207</article-id>
<article-id pub-id-type="doi">10.31134/ap.91.4.3</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Politerapia en niños y adolescentes hospitalizados en cuidados moderados en el Hospital Pediátrico del Centro Hospitalario Pereira Rossell (julio-setiembre 2019)]]></article-title>
<article-title xml:lang="en"><![CDATA[Polytherapy in children and adolescents hospitalized in moderate care at the Pereira Rossell Pediatric Hospital. July-september 2019]]></article-title>
<article-title xml:lang="pt"><![CDATA[Politerapia em crianças e adolescentes hospitalizados no cuidado moderado do Hospital Pediátrico Pereira Rossell. Julho-setembro de 2019]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[Antonella]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[Sofía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Behrens]]></surname>
<given-names><![CDATA[Helga]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Bentos-Pereira]]></surname>
<given-names><![CDATA[Camila]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Catterina]]></surname>
<given-names><![CDATA[Ximenna Di]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Maurente]]></surname>
<given-names><![CDATA[Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[Loreley]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,UDELAR Facultad de Medicina ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica B]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,UDELAR Facultad de Medicina Clínica Pediátrica B]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>91</volume>
<numero>4</numero>
<fpage>207</fpage>
<lpage>224</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-12492020000400207&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-12492020000400207&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-12492020000400207&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen:  Introducción: la politerapia es una preocupación creciente dentro de la población pediátrica, definida como el consumo de dos o más fármacos, ya que se asocia a un mayor riesgo de reacciones adversas. Para lograr comprender en profundidad las consecuencias de la politerapia, es necesario estudiar el espectro completo de medicamentos utilizados en este grupo poblacional.  Objetivo:  describir la politerapia en niños y adolescentes de entre 2 y 15 años que consumen dos o más fármacos de forma crónica, hospitalizados en salas de cuidados moderados del Hospital Pediátrico del Centro Hospitalario Pereira Rossell durante los meses de julio a setiembre del año 2019.  Metodología: encuesta realizada a los cuidadores de niños y adolescentes de entre 2 y 15 años que consumen dos o más fármacos de forma crónica. Se analizaron las siguientes variables: edad, sexo, grupos de fármacos, cantidad de principios activos, combinaciones más frecuentes, diagnóstico, prescripción off-label, profesional que prescribe el tratamiento y profesional que lo monitoriza.  Resultados:  se realizaron 82 encuestas, 53 niños y 29 adolescentes. Predominó el consumo de dos fármacos para todos los rangos etarios y para ambos sexos. De un total de 251 fármacos registrados, los de mayor frecuencia fueron los correspondientes a la esfera nerviosa (n=124), seguidos por los de la esfera respiratoria (n=71), no encontrándose diferencias significativas en cuanto a sexo, pero sí en cuanto a edad. Respecto a las prescripciones de fármacos de la esfera nerviosa, el 41,25% fueron off-label, no observándose ninguna para fármacos de la esfera respiratoria.  Conclusión: el mayor consumo en forma de politerapia corresponde a psicofármacos y antiasmáticos. De los pacientes medicados con psicofármacos, la mayor parte no contaba con diagnóstico previo y presentaba una alta frecuencia de prescripciones off-label. Se destaca la importancia de actualizaciones periódicas de las guías referentes de prescripción a nivel nacional.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary:  Introduction: polytherapy is a growing concern in the pediatric population: it is defined as the consumption of two or more drugs, since it is associated with an increased risk of side effects. It is necessary to study the broad range of drugs used in this population in order to gain a thorough understanding of the consequences of polytherapy.  Objective: describe polytherapy in children and adolescents between 2 and 15 years of age who consume two or more drugs chronically, hospitalized at the moderate care ward of the Pereira Rossell Pediatric Hospital in July-September 2019.  Methodology: survey to caregivers of children and adolescents between 2 and 15 years of age who take two or more drugs chronically. The following variables were analyzed: age, sex, groups of drugs, quantity of active ingredients, most frequent combinations, diagnosis, &#8220;off-label&#8221; prescription, health professional who prescribed the treatment and health professional who monitored it.  Results: 82 surveys were carried out, 53 children and 29 adolescents. The consumption of two drugs was predominant for all age ranges and for both sexes. Of a total of 251 drugs recorded, the most frequent were those related to the nervous system (n = 124) followed by those of the respiratory system (n = 71), no significant differences were found regarding sex, however age did show significant differences. 41.25% of the nervous system drug prescriptions were &#8216;off-label&#8217;, while none were off-label for the case of respiratory drugs.  Conclusion: psychotropic and anti-asthmatic drugs are the highest consumed in cases of polytherapy. Most of the patients who took psychotropic drugs did not have a previous diagnosis and had frequently been prescribed &#8216;off-label&#8217; drugs. We note the importance of periodic updates to the national prescription guidelines.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[ Resumo:  Introdução: a politerapia é uma preocupação crescente na população pediátrica. Define-se como o consumo de dois ou mais medicamentos, pois ela está associada a um risco aumentado de reações adversas. Para entender completamente as consequências da politerapia, é necessário estudar todo o espectro de medicamentos utilizados nesse grupo populacional.  Objetivo:  descrever a politerapia em crianças e adolescentes entre 2 e 15 anos de idade que consomem dois ou mais medicamentos cronicamente, internados em salas de atendimento moderado do Centro Pediátrico Hospitalário Pereira Rossell, de julho a setembro do 2019.  Metodologia:  pesquisa a cuidadores de crianças e adolescentes entre 2 e 15 anos de idade que consomem dois ou mais medicamentos cronicamente. Analisaram-se as seguintes variáveis: idade, sexo, grupos de medicamentos, quantidade de princípios ativos, combinações mais frequentes, diagnóstico, prescrição &#8216;off label&#8217;, profissional da saúde que prescreveu o tratamento e profissional da saúde que o acompanhou.  Resultados:  realizaram-se 82 pesquisas, 53 crianças e 29 adolescentes. O consumo de dois medicamentos predominou em todas as faixas etárias e em ambos os sexos. De um total de 251 medicamentos registrados, os mais frequentes foram os correspondentes ao sistema nervoso (n = 124), seguidos pelos do sistema respiratório (n = 71), não se encontrando diferenças significativas em termos de sexo, mas sim em termos de idade. Em relação às prescrições para medicamentos do sistema nervoso, 41,25% foram &#8220;off label&#8221;, não houve medicamentos &#8216;off-label&#8217; para o sistema respiratório  Conclusão:  o maior consumo de politerapia foi de psicotrópicos e anti-asmáticos. Dos pacientes medicados com medicamentos psicotrópicos, a maioria não tinha diagnóstico prévio e apresentava alta frequência de prescrições &#8216;off label&#8217;. É importante atualizar periodicamente as diretrizes nacionais de prescrição.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Combinación de medicamentos]]></kwd>
<kwd lng="es"><![CDATA[Adolescente]]></kwd>
<kwd lng="es"><![CDATA[Niño]]></kwd>
<kwd lng="en"><![CDATA[Drug combinations]]></kwd>
<kwd lng="en"><![CDATA[Adolescent]]></kwd>
<kwd lng="en"><![CDATA[Child]]></kwd>
<kwd lng="pt"><![CDATA[Combinação de medicamentos]]></kwd>
<kwd lng="pt"><![CDATA[Adolescente]]></kwd>
<kwd lng="pt"><![CDATA[Criança]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Compas]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Jaser]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dunn]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodriguez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Coping with chronic illness in childhood and adolescence]]></article-title>
<source><![CDATA[Annu Rev Clin Psychol]]></source>
<year>2012</year>
<volume>8</volume>
<page-range>455-80</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wolfe]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Tamburlini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Blair]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van den]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health services for children in western Europe]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2013</year>
<volume>381</volume>
<numero>9873</numero>
<issue>9873</issue>
<page-range>1224-34</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horace]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ahmed]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polypharmacy in pediatric patients and opportunities for pharmacists' involvement]]></article-title>
<source><![CDATA[Integr Pharm Res Pract]]></source>
<year>2015</year>
<volume>4</volume>
<page-range>113-26</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>Organización Mundial de la Salud</collab>
<source><![CDATA[Enfermedades crónicas]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Consolini]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Niños con enfermedades crónicas]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Kenilworth, NJ ]]></publisher-loc>
<publisher-name><![CDATA[Merck Sharp &amp; Dohme]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Visualización de indicadores]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Washington, DC ]]></publisher-loc>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bakaki]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Horace]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Winterstein]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Waldron]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Staley]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Defining pediatric polypharmacy a scoping review]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2018</year>
<volume>13</volume>
<numero>11</numero>
<issue>11</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baker]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Feinstein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ma]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Bolen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Golchin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variation of the prevalence of pediatric polypharmacy a scoping review]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2019</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>275-87</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bushardt]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Massey]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Ariail]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Simpson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Polypharmacy misleading, but manageable]]></article-title>
<source><![CDATA[Clin Interv Aging]]></source>
<year>2008</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>383-9</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhatt]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Potential drug-drug interactions and the picu should we worry about icu polypharmacy?]]></article-title>
<source><![CDATA[Pediatr Crit Care Med]]></source>
<year>2016</year>
<volume>17</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>470-2</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baek]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Shin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Trends in polypharmacy over 12 years and changes in its social gradients in South Korea]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2018</year>
<volume>13</volume>
<numero>9</numero>
<issue>9</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Misra]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Khera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Khera]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pediatric pharmacovigilance in an institute of national importance Journey has just begun]]></article-title>
<source><![CDATA[Indian J Pharmacol]]></source>
<year>2017</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>390-5</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morden]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Goodman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pediatric polypharmacy time to lock the medicine cabinet?]]></article-title>
<source><![CDATA[Arch Pediatr Adolesc Med]]></source>
<year>2012</year>
<volume>166</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>91-2</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Balan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hassali]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mak]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Two decades of off-label prescribing in children a literature review]]></article-title>
<source><![CDATA[World J Pediatr]]></source>
<year>2018</year>
<volume>14</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>528-40</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kornø]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Aagaard]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Off-label prescribing of antipsychotics in a danish child and adolescent mental health center a register-based study]]></article-title>
<source><![CDATA[J Res Pharm Pract]]></source>
<year>2018</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>205-9</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kirkham]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nunn]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Pirmohamed]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adverse drug reactions and off-label and unlicensed medicines in children a prospective cohort study of unplanned admissions to a paediatric hospital]]></article-title>
<source><![CDATA[Br J Clin Pharmacol]]></source>
<year>2014</year>
<volume>77</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>545-53</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zunino]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Assandri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cartategui]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martorell]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Minetti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Conocimiento de la prescripción de medicamentos off label en pediatría]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2019</year>
<volume>90</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>195-202</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<collab>Ministerio de Salud Pública</collab>
<collab>Dirección General de Salud</collab>
<collab>Área Programática de Adolescencia y Juventud</collab>
<source><![CDATA[Guía para la atención integral de la salud de adolescentes]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvariño]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Torterolo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Formulario terapéutico de medicamentos]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[MSP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aquino]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Asma en el niño motivos de hospitalización]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2001</year>
<volume>72</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>262-5</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pinchak]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Matelzonas]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Da Rosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Boix]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gutiérrez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Calidad de vida del niño asmático y su cuidador en centros públicos y privados de Montevideo (2009 a 2010)]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2013</year>
<volume>84</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>10-7</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dharmage]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Perret]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Custovic]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of asthma in children and adults]]></article-title>
<source><![CDATA[Front Pediatr]]></source>
<year>2019</year>
<volume>7</volume>
<page-range>246</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Akinbami]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rossen]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Changing trends in asthma prevalence among children]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2016</year>
<volume>137</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azmeh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Greydanus]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Agana]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Dickson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ischander]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Update in pediatric asthma selected issues]]></article-title>
<source><![CDATA[Dis Mon]]></source>
<year>2020</year>
<volume>66</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>100886</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[La Maison]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Munhoz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Anselmi]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Matijasevich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence and risk factors of psychiatric disorders in early adolescence 2004 Pelotas (Brazil) birth cohort]]></article-title>
<source><![CDATA[Soc Psychiatry Psychiatr Epidemiol]]></source>
<year>2018</year>
<volume>53</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>685-97</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<collab>Deparment of Gender Women and Health</collab>
<source><![CDATA[Gender and mental health]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mental health in low- and middle-income countries]]></article-title>
<source><![CDATA[Br Med Bull]]></source>
<year>2007</year>
<volume>81-82</volume>
<page-range>81-96</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mastroianni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ackermann]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Catenaccio]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Telechea]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Giachetto]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Características del uso de psicofármacos en niños hospitalizados]]></article-title>
<source><![CDATA[Arch Pediatr Urug]]></source>
<year>2017</year>
<volume>88</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>132-41</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Janin]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La desatención y la hiperactividad en los niños como modo de manifestar el sufrimiento psíquico]]></article-title>
<source><![CDATA[Psicol Conoc Soc]]></source>
<year>2013</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>55-79</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Untoiglich]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Affonso]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Azevedo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Angelucci]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de Bastos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Geraldi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[En la infancia los diagnósticos se escriben con lápiz: la patologización de las diferencias en la clínica y la educación. (Conjunciones Tomo 33)]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Buenos Aires ]]></publisher-loc>
<publisher-name><![CDATA[Noveduc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Joffre]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principios generales sobre la psicofarmacoterapia en niños y adolescentes una revisión]]></article-title>
<source><![CDATA[Salud Ment]]></source>
<year>2006</year>
<volume>29</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>30-9</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vidal]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Findling]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Focused Review on the treatment of pediatric patients with atypical antipsychotics]]></article-title>
<source><![CDATA[J Child Adolesc Psychopharmacol]]></source>
<year>2018</year>
<volume>28</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>582-605</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shafiq]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pringsheim]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using antipsychotics for behavioral problems in children]]></article-title>
<source><![CDATA[Expert Opin Pharmacother]]></source>
<year>2018</year>
<volume>19</volume>
<numero>13</numero>
<issue>13</issue>
<page-range>1475-88</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lares]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sosa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bañuelos]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Guillé]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Farmacoepidemiología de psicofármacos empleados en la práctica pediátrica en el Servicio de Psiquiatría Infantil del Hospital General de Durango, México]]></article-title>
<source><![CDATA[Bol Med Hosp Infant Mex]]></source>
<year>2010</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>27-36</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Srisurapanont]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Maneeton]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Maneeton]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quetiapina para la esquizofrenia]]></article-title>
<source><![CDATA[Biblioteca Cochrane Plus]]></source>
<year>2008</year>
<volume>3</volume>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Asmal]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Flegar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Rummel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Komossa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Leucht]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quetiapine versus other atypical antipsychotics for schizophrenia]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2013</year>
<numero>11</numero>
<issue>11</issue>
<page-range>CD006625</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Agrawal]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mula]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of psychoses in patients with epilepsy an update]]></article-title>
<source><![CDATA[Ther Adv Psychopharmacol]]></source>
<year>2019</year>
<volume>9</volume>
</nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Snoek]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Durward]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Levomepromazine for difficult sedation in pediatric intensive care]]></article-title>
<source><![CDATA[J Pediatr Intensive Care]]></source>
<year>2014</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>53-7</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hohl]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stenekes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Harlos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shepherd]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[McClement]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chochinov]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Methotrimeprazine for the management of end-of-life symptoms in infants and children]]></article-title>
<source><![CDATA[J Palliat Care]]></source>
<year>2013</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>178-85</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pringsheim]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lam]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ching]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Patten]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic and neurological complications of second-generation antipsychotic use in children a systematic review and meta-analysis of randomized controlled trials]]></article-title>
<source><![CDATA[Drug Saf]]></source>
<year>2011</year>
<volume>34</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>651-68</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pringsheim]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lam]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Patten]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The pharmacoepidemiology of antipsychotic medications for Canadian children and adolescents 2005-2009]]></article-title>
<source><![CDATA[J Child Adolesc Psychopharmacol]]></source>
<year>2011</year>
<volume>21</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>537-43</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Speranza]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tamosiunas]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de medicamentos fuera de prospecto Uso off label de medicamentos ¿un mal necesario??]]></article-title>
<source><![CDATA[Bol Farmacol]]></source>
<year>2016</year>
<volume>7</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>1-6</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ballard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Heard]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Stranded on antipsychotics role of the pediatric clinician]]></article-title>
<source><![CDATA[Clin Pediatr (Phila)]]></source>
<year>2019</year>
<volume>58</volume>
<numero>11-12</numero>
<issue>11-12</issue>
<page-range>1153-7</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iapadre]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Balagura]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Zagaroli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Striano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Verrotti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacokinetics and drug interaction of antiepileptic drugs in children and adolescents]]></article-title>
<source><![CDATA[Paediatr Drugs]]></source>
<year>2018</year>
<volume>20</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>429-53</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Flórez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Armijo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mediavilla]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Farmacología humana]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier-Masson]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tran]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zito]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Safer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hundley]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National trends in pediatric use of anticonvulsants]]></article-title>
<source><![CDATA[Psychiatr Serv]]></source>
<year>2012</year>
<volume>63</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1095-101</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karlsson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Wide]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Wettermark]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[von Euler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Utilization of antiepileptic medicines in swedish children and adolescents with different diagnoses]]></article-title>
<source><![CDATA[Basic Clin Pharmacol Toxicol]]></source>
<year>2018</year>
<volume>123</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>94-100</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ettinger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Argoff]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of antiepileptic drugs for nonepileptic conditions psychiatric disorders and chronic pain]]></article-title>
<source><![CDATA[Neurotherapeutics]]></source>
<year>2007</year>
<volume>4</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>75-83</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perucca]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mula]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antiepileptic drug effects on mood and behavior molecular targets]]></article-title>
<source><![CDATA[Epilepsy Behav]]></source>
<year>2013</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>440-9</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncriff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El litio y otros fármacos para el trastorno maníaco-depresivo y bipolar]]></article-title>
<source><![CDATA[Rev Asoc Esp Neuropsiq]]></source>
<year>2018</year>
<volume>38</volume>
<numero>133</numero>
<issue>133</issue>
<page-range>283-99</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borges]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children Brazilian Regulatory Agency versus FDA]]></article-title>
<source><![CDATA[Int J Clin Pharm]]></source>
<year>2013</year>
<volume>35</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>425-31</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Owens]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sodium valproate in psychiatric practice time for a change in perception]]></article-title>
<source><![CDATA[Br J Psychiatry]]></source>
<year>2019</year>
<volume>215</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>516-8</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Codesal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Chamorro]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antiepilépticos en psicogeriatría uso clínico práctico más allá de la epilepsia]]></article-title>
<source><![CDATA[Psicogeriatría]]></source>
<year>2010</year>
<volume>2</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>183-99</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="book">
<collab>Global Initiative for Asthma</collab>
<source><![CDATA[Global strategy for asthma management and prevention, 2019.]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Fontana, WI ]]></publisher-loc>
<publisher-name><![CDATA[GINA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mojtabai]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Olfson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[National trends in psychotropic medication polypharmacy in office-based psychiatry]]></article-title>
<source><![CDATA[Arch Gen Psychiatry]]></source>
<year>2010</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>26-36</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pidano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Honigfeld]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pediatric psychopharmacology context, model programs, and considerations for care]]></article-title>
<source><![CDATA[Psychiatr Serv]]></source>
<year>2012</year>
<volume>63</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>929-34</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psicofarmacología en niños , niñas y adolescentes una aproximación a la terapéutica]]></article-title>
<source><![CDATA[MEDUNAB]]></source>
<year>2002</year>
<volume>5</volume>
<numero>15</numero>
<issue>15</issue>
<page-range>195-202</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
